Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature

Currently, there are a few systemic treatment options for patients with metastatic colorectal cancer (mCRC). Targeted therapy used in this setting includes the use of monoclonal antibodies, such as cetuximab or panitumumab, directed against epidermal growth factor receptor. The aim of the present st...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Main Authors: STREB, JOANNA, PÜSKÜLLÜOĞLU, MIROSLAWA, GLANOWSKA, IZABELA, OCHENDUSZKO, SEBASTIAN, KONOPKA, KAMIL, ŁUPKOWSKI, RADOSLAW, MICHALOWSKA-KACZMARCZYK, ANNA, BOCHENEK-CIBOR, JUSTYNA, MAJKA, MARCIN, KRZEMIENIECKI, KRZYSZTOF
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2015
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4665193/
https://ncbi.nlm.nih.gov/pubmed/26788202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3800
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares